Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'Cam'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Camp BJ The Alkaloid of Acacia berlandieri N-Methyl-B-Phenylethylamine : A dis... Graduate School of A... 1956
Cameron K Hallucinogenic drugs. Specific problems Lancet 1961
Woolley DW, Campbell NK Serotonin-like and antiserotonin properties of psilocybin and psilocin Science 1962
Cameron K Some experiences with LSD in the treatment of adolescent boys Hallucinogenic drugs... 1963
Martínez del Campo Enríqu... Acción farmacológica de la psilocibina Tesis 1964
DC Cameron Drug Dependence: No Longer Can We "Let George Do It" Amer. J. Psychiat. (... 1966
Adams HR, Camp BJ The isolation and identification of three alkaloids from Acacia Berlan... Toxicon 1966
Minghetti A, Arcamone F Studies concerning the biogenesis of natural derivatives of lysergic a... Experientia 1969
Campbell DB, Turner P Plasma concentrations of fenfluramine and its metabolite, norfenfluram... Br J Pharmacol 1971
Cameron OG, Appel JB Conditioned suppression of bar-pressing behavior by stimuli associated... J. exp. Anal. Behav. 1972
Cameron OG, Appel JB A behavioral and pharmacological analysis of some discriminable proper... Psychopharmacologia 1973
Campbell H, Cline W, Evan... Comparison of the effects of dexamphetamine and 1-benzylpiperazine in ... Eur J Clin Pharmacol 1973
Cameron OG, Appel JB Drug Induced Conditioned Suppression: Specificity Cue To Drug Employed... Pharmacol. Biochem. ... 1976
O'Brien BA, Bonicamp JM, ... Differentiation of Amphetamine and Its Major Hallucinogenic Derivative... J Anal Toxicol 1982
Marchant NC, Breen MA, Wa... Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in... Xenobiotica 1992
Campkin NJ, Davies UM Treatment of 'ecstasy' overdose with dantrolene Anaesthesia 1993
Campbell DB The use of toxicokinetics for the safety assessment of drugs acting in... Mol Neurobiol 1995
Campbell DB Extrapolation from animals to man: the integration of pharmacokinetics... Ann N Y Acad Sci 1996
Donnelly-Roberts DL, Putt... ABT-594 [R-5-2-azetidinylmethoxy-2-chloropyridine]: a novel, orally ef... J Pharmacol Exp Ther 1998
Mas M, Farre M, de la Tor... Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... J Pharmacol Exp Ther 1999
Ortuno J, Pizarro N, Farr... Quantification of 3,4-methylenedioxymetamphetamine and its metabolites... J Chromatogr B Biome... 1999
Carvalho JC, Ferreira LP,... Anti-inflammatory activity of flavone and some of its derivates from V... J Ethnopharmacol 1999
Cording CJ, DeLuca R, Cam... A fatality related to the veterinary anesthetic telazol J Anal Toxicol 1999
de la Torre R, Farré M, O... Non-linear pharmacokinetics of MDMA (`ecstasy') in humans Br J Clin Pharmacol 2000
de la Torre R, Farre M, O... Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br J Clin Pharmacol 2000
Cami J, Farre M, et al Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'): p... J Clin Psychopharmac... 2000
de la Torre R, Farre M, R... Pharmacology of MDMA in humans Ann N Y Acad Sci 2000
Pacifici R, Zuccaro P, Fa... Immunomodulating activity of MDMA Ann N Y Acad Sci 2000
Sanchez V, Camarero J, Es... The mechanisms involved in the long-lasting neuroprotective effect of ... Br J Pharmacol 2001
Esteban B, O'Shea E, Cama... 3,4-Methylenedioxymethamphetamine induces monoamine release, but not t... Psychopharmacology (... 2001
O'Shea E, Esteban B, Cama... Effect of GBR 12909 and fluoxetine on the acute and long term changes ... Neuropharmacology 2001
Colado MI, Camarero J, Me... A study of the mechanisms involved in the neurotoxic action of 3,4- me... Br J Pharmacol 2001
Farré M, Roset PN, de la ... Interaction of Paroxetine and MDMA in humans College on Problems... 2002
Byard RW, Rodgers NG, Jam... Death and paramethoxyamphetamine -- an evolving problem Med J Aust 2002
Campo JV, McNabb J, Perel... Kava-induced fulminant hepatic failure J Am Acad Child Adol... 2002
Hernandez-Lopez C, Farre ... 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions i... J Pharmacol Exp Ther 2002
Pizarro N, Ortuno J, Farr... Determination of MDMA and its metabolites in blood and urine by gas ch... J Anal Toxicol 2002
Camarero J, Sanchez V, O'... Studies, using in vivo microdialysis, on the effect of the dopamine up... J Neurochem 2002
Fergusson DM, Horwood LJ,... Cannabis dependence and psychotic symptoms in young people Psychol Med 2003
Sanchez V, Camarero J, O\... Differential effect of dietary selenium on the long-term neurotoxicity... Neuropharmacology 2003
Pubill D, Canudas AM, Pal... Different glial response to methamphetamine- and methylenedioxymethamp... Naunyn Schmiedebergs... 2003
Koprich JB, Chen EY, Kana... Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters explorator... Neurotoxicol Teratol 2003
Vallee JN, Crozier S, Gui... Acute basilar artery occlusion treated by thromboaspiration in a cocai... Neurology 2003
Cameron D Much, much more important than that Addiction Reasearch ... 2003
de la Torre R, Farre M, R... Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposit... Ther Drug Monit 2004
Farre M, De La Torre R, O... Repeated doses administration of MDMA in humans: pharmacological effec... Psychopharmacology (... 2004
Orio L, O'Shea E, Sanchez... 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels a... J Neurochem 2004
de la Torre R, Farre M, O... MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in ni... Eur J Clin Pharmacol 2005
Gobbi G, Bambico FR, Mang... Antidepressant-like activity and modulation of brain monoaminergic tra... pnas 2005
Campos AR, Santos FA, Rao... Ketamine-induced potentiation of morphine analgesia in rat tail-flick ... Biol Pharm Bull 2006
Camarasa J, Pubill D, Esc... Association of caffeine to MDMA does not increase antinociception but ... Brain Res 2006
Williams MT, Herring NR, ... Alterations in Body Temperature, Corticosterone, and Behavior Followin... Neuropsychopharmacol... 2006
Maeng S, Zarate CA, Du J,... Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine:... Biol Psychiatry 2007
McCambridge J A case study of publication bias in an influential series of reviews o... Drug Alcohol Rev 2007
Chipana C, Camarasa J, Pu... Memantine prevents MDMA-induced neurotoxicity Neurotoxicology 2008
Camarasa J, Marimon JM, R... Memantine prevents the cognitive impairment induced by 3,4-methylenedi... Eur J Pharmacol 2008
Greely H, Sahakian B, Har... Towards responsible use of cognitive-enhancing drugs by the healthy Nature 2008
Tadini KA, Campos PM In vivo skin effects of a dimethylaminoethanol (DMAE) based formulatio... Pharmazie 2009
Camilleri A, Johnston MR,... Chemical analysis of four capsules containing the controlled substance... Forensic Sci Int 2010
Martínez-Clemente J, Escu... Interaction of mephedrone with dopamine and serotonin targets in rats Eur Neuropsychopharm... 2011
Jimenez M, Chiuve SE, Gly... Alcohol consumption and risk of stroke in women Stroke 2012
Cameron KN, Kolanos R, So... Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV)... Br J Pharmacol 2012
Cameron K, Kolanos R, Ver... Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents o... Psychopharmacology (... 2013
Daniulaityte R, Carlson R... I just wanted to tell you that loperamide WILL WORK: a web-based study... Drug Alcohol Depend 2013
McIntyre IM, Trochta A, S... Mitragynine 'Kratom' related fatality: a case report with postmortem c... J Anal Toxicol 2015
Csete J, Kamarulzaman A, ... Public health and international drug policy Lancet 2016
Xi-Ping Huang, Che T, Man... Pharmacology OF W-18 AND W-15 bioRxiv 2016
Elliott L, Benoit E, Camp... The long tail of a demon drug: The 'bath salts' risk environment Int J Drug Policy 2017
Ly C, Greb AC, Cameron LP... Psychedelics Promote Structural and Functional Neural Plasticity Cell Rep 2018
Meader N, Mdege N, McCamb... The public health evidence-base on novel psychoactive substance use: s... J Public Health (Oxf... 2018
Cameron LP, Benson CJ, De... Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltrypt... ACS Chem Neurosci 2019